Evaluation of the child with atopic dermatitis

Clinical and Experimental Allergy

Volumn 42, Issue 3, 2012, Pages 352-362

  De Bruin Weller, M S ^a   Knulst, A C ^a   Meijer, Y ^b   Bruijnzeel Koomen, C A F M ^a   Pasmans, S G M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOSINOPHIL CATIONIC PROTEIN; FOOD ALLERGEN; SOLUBLE E SELECTIN; SOLUBLE VASCULAR CELL ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACRODERMATITIS ENTEROPATHICA; ALLERGIC RHINITIS; ALLERGY TEST; ASTHMA; ATOPIC DERMATITIS; CLINICAL EVALUATION; CORTICOSTEROID THERAPY; CUTANEOUS T CELL LYMPHOMA; DERMATOMYCOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ECZEMA; FOOD ALLERGY; HISTIOCYTOSIS X; HUMAN; NETHERTON DISEASE; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; REVIEW; SCABIES; SCORING SYSTEM; SEBORRHEIC DERMATITIS; WISKOTT ALDRICH SYNDROME;

CHILD; DERMATITIS, ATOPIC; HUMANS;

EID: 84857355385     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03899.x     Document Type: Review

References (75)

1. Williams H, Robertson C, Stewart A et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999;103:125-38.
2. Hoare C, Li Wan PA, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4:1-191.
3. Eller E, Kjaer HF, Host A, Andersen KE, Bindslev-Jensen C. Development of atopic dermatitis in the DARC birth cohort. Pediatr Allergy Immunol 2010; 21:307-14.
4. Emerson RM, Williams HC, Allen BR. Severity distribution of atopic dermatitis in the community and its relationship to secondary referral. Br J Dermatol 1998; 139:73-6.
5. Smidesang I, Saunes M, Storro O, Oien T, Holmen TL, Johnsen R et al. Atopic dermatitis among 2-year olds; high prevalence, but predominantly mild disease-the PACT study, Norway. Pediatr Dermatol 2008; 25:13-8.
6. Broberg A, Svensson A, Borres MP, Berg R. Atopic dermatitis in 5-6-year-old Swedish children: cumulative incidence, point prevalence, and severity scoring. Allergy 2000; 55:1025-9.
7. Ben-Gashir MA, Seed PT, Hay RJ. Predictors of atopic dermatitis severity over time. J Am Acad Dermatol 2004; 50:349-56.
8. Illi S, von ME, Lau S, Nickel R, Gruber C, Niggemann B et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113:925-31.
9. Weidinger S, Rodriguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007; 127:724-6.
10. Barker JN, Palmer CN, Zhao Y, Liao H, Hull PR, Lee SP et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007; 127:564-7.
11. van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009; 339:b2433.
12. de Benedictis FM, Franceschini F, Hill D, Naspitz C, Simons FE, Wahn U et al. The allergic sensitization in infants with atopic eczema from different countries. Allergy 2009; 64:295-303.
13. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol 2010; 125(2 Suppl 2):S116-S125.
14. van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007; 120:565-9.
15. Simpson EL, Hanifin JM. Atopic dermatitis. J Am Acad Dermatol 2005; 53:115-28.
16. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92(Suppl.):44-7.
17. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8:483-91.
18. Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. diagnostic criteria for atopic dermatitis working party. Br J Dermatol 1996; 135:12-7.
19. Bos JD, Van Leent EJ, Sillevis Smitt JH. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 1998; 7:132-8.
20. Flohr C, Weiland SK, Weinmayr G, Bjorksten B, Braback L, Brunekreef B et al. The role of atopic sensitization in flexural eczema: findings from the international study of asthma and allergies in childhood phase two. J Allergy Clin Immunol 2008; 121:141-7.
21. Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008; 158:754-65.
22. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am 2010; 30:269-80.
23. Lowe AJ, Hosking CS, Bennett CM, Carlin JB, Abramson MJ, Hill DJ et al. Skin prick test can identify eczematous infants at risk of asthma and allergic rhinitis. Clin Exp Allergy 2007; 37:1624-31.
24. Muller S, Marenholz I, Lee YA, Sengler C, Zitnik SE, Griffioen RW et al. Association of Filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the early treatment of the atopic child (ETAC) population. Pediatr Allergy Immunol 2009; 20:358-61.
25. Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008; 372:1058-64.
26. Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007; 120:1389-98.
27. Housman TS, Patel MJ, Camacho F, Feldman SR, Fleischer AB Jr, Balkrishnan R. Use of the self-administered eczema area and severity index by parent caregivers: results of a validation study. Br J Dermatol 2002; 147:1192-8.
28. van Velsen SG, Knol MJ, Haeck IM, Bruijnzeel-Koomen CA, Pasmans SG. The self-administered eczema area and severity index in children with moderate to severe atopic dermatitis: better estimation of ad body surface area than severity. Pediatr Dermatol 2010; 27:470-5.
29. Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, Mulder PG, Oranje AP. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol 1999; 79:356-9.
30. Barbier N, Paul C, Luger T, Allen R, de Prost Y, Papp K et al. Validation of the eczema area and severity index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol 2004; 150:96-102.
31. Schmitt J, Williams H. Harmonising outcome measures for eczema (HOME). Report from the first international consensus meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 2010; 163:1166-8.
32. Gutgesell C, Heise S, Seubert A, Stichtenoth DO, Frolich JC, Neumann C. Comparison of different activity parameters in atopic dermatitis: correlation with clinical scores. Br J Dermatol 2002; 147:914-9.
33. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De JE, Bruijnzeel-Koomen C et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004; 113:334-40.
34. Fujisawa T, Nagao M, Hiraguchi Y, Katsumata H, Nishimori H, Iguchi K et al. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Pediatr Allergy Immunol 2009; 20:633-41.
35. Matricardi PM, Bockelbrink A, Keil T, Gruber C, Niggemann B, Hamelmann E et al. Dynamic evolution of serum immunoglobulin E to airborne allergens throughout childhood: results from the multi-centre allergy study birth cohort. Clin Exp Allergy 2009; 39:1551-7.
36. Harris JM, Williams HC, White C, Moffat S, Mills P, Newman Taylor AJ et al. Early allergen exposure and atopic eczema. Br J Dermatol 2007; 156:698-704.
37. Corver K, Kerkhof M, Brussee JE, Brunekreef B, van Strien RT, Vos AP et al. House dust mite allergen reduction and allergy at 4 yr: follow up of the PIAMA-study. Pediatr Allergy Immunol 2006; 17:329-36.
38. Darsow U, Laifaoui J, Kerschenlohr K, Wollenberg A, Przybilla B, Wuthrich B et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004; 59:1318-25.
39. Kramer U, Weidinger S, Darsow U, Mohrenschlager M, Ring J, Behrendt H. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema. J Invest Dermatol 2005; 124:514-23.
40. Bruin-Weller MS, Knol EF, Bruijnzeel-Koomen CA. Atopy patch testing-a diagnostic tool? Allergy 1999; 54:784-91.
41. Oldhoff JM, Bihari IC, Knol EF, Bruijnzeel-Koomen CA, Bruin-Weller MS. Atopy patch test in patients with atopic eczema/dermatitis syndrome: comparison of petrolatum and aqueous solution as a vehicle. Allergy 2004; 59:451-6.
42. Fuiano N, Fusilli S, Incorvaia C. House dust mite-related allergic diseases: role of skin prick test, atopy patch test, and RAST in the diagnosis of different manifestations of allergy. Eur J Pediatr 2010; 169:819-24.
43. Turjanmaa K, Darsow U, Niggemann B, Rance F, Vanto T, Werfel T. EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy 2006; 61:1377-84.
44. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347:15-8.
45. Oosting AJ, Bruin-Weller MS, Terreehorst I, Tempels-Pavlica Z, Aalberse RC, De Monchy JG et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol 2002; 110:500-6.
46. Gutgesell C, Heise S, Seubert S, Seubert A, Domhof S, Brunner E et al. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol 2001; 145:70-4.
47. Ricci G, Patrizi A, Specchia F, Menna L, Bottau P, D'Angelo V et al. Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol 2000; 143:379-84.
48. Fleischer DM, Bock SA, Spears GC, Wilson CG, Miyazawa NK, Gleason MC et al. Oral food challenges in children with a diagnosis of food allergy. J Pediatr 2011; 158:578-83.
49. Werfel T, Breuer K. Role of food allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol 2004; 4:379-85.
50. Werfel T, Ballmer-Weber B, Eigenmann PA, Niggemann B, Rance F, Turjanmaa K et al. Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN. Allergy 2007; 62:723-8.
51. Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101:E8.
52. Eller E, Kjaer HF, Host A, Andersen KE, Bindslev-Jensen C. Food allergy and food sensitization in early childhood: results from the DARC cohort. Allergy 2009; 64:1023-9.
53. Hill DJ, Hosking CS. Food allergy and atopic dermatitis in infancy: an epidemiologic study. Pediatr Allergy Immunol 2004; 15:421-7.
54. Brown SJ, Asai Y, Cordell HJ, Campbell LE, Zhao Y, Liao H et al. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 2011; 127:661-7.
55. Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001; 107:891-6.
56. van Nieuwaal NH, Lasfar W, Meijer Y, Kentie PA, Flinterman AE, Pasmans SG et al. Utility of peanut-specific IgE levels in predicting the outcome of double-blind, placebo-controlled food 's. J Allergy Clin Immunol 2010; 125:1391-2.
57. Niggemann B, Sielaff B, Beyer K, Binder C, Wahn U. Outcome of double-blind, placebo-controlled food challenge tests in 107 children with atopic dermatitis. Clin Exp Allergy 1999; 29:91-6.
58. Breuer K, Heratizadeh A, Wulf A, Baumann U, Constien A, Tetau D et al. Late eczematous reactions to food in children with atopic dermatitis. Clin Exp Allergy 2004; 34:817-24.
59. Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for improving established atopic eczema in adults and children: systematic review. Allergy 2009; 64:258-64.
60. Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev 2008; CD005203.
61. Lever R, MacDonald C, Waugh P, Aitchison T. Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 1998; 9:13-9.
62. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The international study of asthma and allergies in childhood (ISAAC) steering committee. Lancet 1998; 351:1225-32.
63. Emerson RM, Charman CR, Williams HC. The nottingham eczema severity score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol 2000; 142:288-97.
64. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155:145-51.
65. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004; 150:284-90.
66. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60:984-92.
67. Lewis-Jones MS, Finlay AY. The children's dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132:942-9.
68. Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993; 69:670-6.
69. Slattery MJ, Essex MJ. Specificity in the association of anxiety, depression, and atopic disorders in a community sample of adolescents. J Psychiatr Res 2010; 45:788-95.
70. Bartlet LB, Westbroek R, White JE. Sleep patterns in children with atopic eczema. Acta Derm Venereol 1997; 77:446-8.
71. Moore K, David TJ, Murray CS, Child F, Arkwright PD. Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol 2006; 154:514-8.
72. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142:931-6.
73. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Am Acad Dermatol 2011; 64:175-92.
74. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P et al. Diagnosis and treatment of atopic dermatitis in children and adults: European academy of allergology and clinical immunology/American academy of allergy, asthma and immunology/PRACTALL consensus report. J Allergy Clin Immunol 2006 July; 118:152-69.
75. Darsow U, Wollenberg A, Simon D, Taieb A, Werfel T, Oranje A et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24:317-28.